Akhondi MM,Ranjbar F,Shirzad M,Ardakani ZB,Kamali K,Mohammad K. .2019 .Practical difficulties in estimating the prevalence of primary infertility in Iran. Int J Fertil Steril, 13(2) : 113-7.
Ahmed HM,Khan M,Yasmin F,Jawaid H,Khalid H,Shigri A .2020 .Awareness regarding causes of infertility among outpatients at a tertiary care hospital in Karachi, Pakistan. , 12(4) : 1-10.
.2013 .cited 2020 Jan]. NICE Clinical Guideline, : .
Pirtea P,de Ziegler D,Poulain M,Ayoubi JM .2020 .Which key performance indicators are optimal to assess clinical management of assisted reproduction cycles? Fertil Steril. , 04(1) : 24-30.
Haahr T,Esteves SC,Humaidan P .2018 .Individualized controlled ovarian stimulation in expected poor-responders: an update. Reprod Biol Endocrinol, 16(1) : 1-9.
Alper MM,Fauser BC .2017 .Ovarian stimulation protocols for IVF: is better than less? Reprod Biomed Online. , 01(4) : 345-53.
Orvieto R. .2019 .HMG versus recombinant FSH plus recombinant LH in ovarian stimulation for IVF: does the source of LH preparation matter? Reprod Biomed. , 08(6) : 1001-6.
Shavit T,Shalom-Paz E,Samara N,Aslih N,Michaeli M,Ellenbogen A .2016 .Comparison between stimulation with highly purified HMG or recombinant FSH in patients undergoing IVF with GnRH antagonist protocol. Gynecol Endocrinol, 32(8) : 629-33.
Bosch E,Broer S,Griesinger G,Grynberg M,Humaidan P,Kolibianakis E .2020 .ESHRE guideline: ovarian stimulation for IVF/ICSI. , : 1-13.
La Marca A,Sunkara SK .2014 .Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update, 20(1) : 124-40.
Ramalho de Carvalho B,Gomes Sobrinho DB,Vieira AD,Resende MP,Barbosa AC,Silva AA .2012 .Ovarian reserve assessment for infertility investigation. ISRN Obstet Gynecol, : 1-10.
Galey-Fontaine J,Cédrin-Durnerin I,Chaïbi R,Massin N,Hugues JN .2005 .Age and ovarian reserve are distinct predictive factors of cycle outcome in low responders. Reprod Biomed Online, 6483(10) : 60808-5.
Stolwijk AM,Wetzels AM,Braat DD .2000 .Cumulative probability of achieving an ongoing pregnancy after in-vitro fertilization and intracytoplasmic sperm injection according to a woman's age, subfertility diagnosis and primary or secondary subfertility. Hum Reprod, 15(1) : 203-9.
Rittenberg V,Seshadri S,Sunkara SK,Sobaleva S,OtengNtim E,El-Toukhy T .2011 .Effect of body mass index on IVF treatment outcome: an updated systematic review and metaanalysis. Reprod Biomed, 06(4) : 421-39.
Setti AS,Braga DP,FigueiraRde C,Vingris L,Iaconelli A,Borges E .2012 .Body mass index is negatively correlated with the response to controlled ovarian stimulation but does not influence oocyte morphology in ICSI cycles. Eur J Obstet Gynecol Reprod Biol, 04(2) : 175-9.
Al-Turki HA .2015 .Prevalence of primary and secondary infertility from tertiary center in eastern Saudi Arabia. Middle East Fertil Soc J, 02(4) : 237-40.
Kumar N,Singh AK .2015 .Trends of male factor infertility, an important cause of infertility: a review of literature. J Hum Reprod Sci, 8(4) : 170370-1208.
Shahrokh Tehraninezhad E,Mehrabi F,Taati R,Kalantar V,Aziminekoo E,Tarafdari A .2016 .Analysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patients. Int J Reprod Biomed, 14(8) : 501-6.
Barad DH,Weghofer A,Gleicher N. .2008 .Comparing antimüllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril, 09(4 Suppl)) : 1553-5.
Revelli A,Martiny G,Delle Piane L,Benedetto C,Rinaudo P,Tur-Kaspa I. .2014 .A critical review of bi-dimensional and threedimensional ultrasound techniques to monitor follicle growth: do they help improving IVF outcome? Reprod Biol Endocrinol. , 12 : 1477-15.
Andersen AN,Devroey P,Arce JC. .2006 .Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod, 21(12) : 3217-27.
Daya S. Updated .2002 .-analysis of recombinant folliclestimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril, 0282(01) : 03246-0.
Duan L,Bao S,Li K,Teng X,Hong L,Zhao X .2017 .Comparing the long-acting and short-acting forms of gonadotropin-releasing hormone agonists in the long protocol of IVF/ICSI Cycles: a retrospective study. J Obstet Gynaecol Res, 43(6) : 1037-42.
Ou J,Xing W,Li Y,Xu Y,Zhou C .2015 .Short versus long gonadotropinreleasing hormone analogue suppression protocols in IVF/ ICSI cycles in patients of various age ranges. PLoS One, 10(7) : .
Andersen AN,Devroey P,Arce JC. .2006 .Clinical outcome following stimulation with highly purified HMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. Hum Reprod, 21(12) : 3217-27.